MAP3K19 Is a Novel Regulator of TGF-β Signaling That Impacts Bleomycin-Induced Lung Injury and Pulmonary Fibrosis

Open Access

Peer-reviewed

Research Article

Stefen A. Boehme ,

* E-mail: sboehme@axikin.com

Affiliation AxikinPharmaceuticals, Inc., San Diego, California, United States of America

http://orcid.org/0000-0001-5560-1645

⨯
Karin Franz-Bacon,

Affiliation DNA Consulting, Inc., San Diego, California, United States of America
⨯
Danielle N. DiTirro,

Current address: Department of Biology, Brandeis University, Waltham, MA, United States of America

Affiliation AxikinPharmaceuticals, Inc., San Diego, California, United States of America
⨯
Tai Wei Ly,

Affiliation AxikinPharmaceuticals, Inc., San Diego, California, United States of America
⨯
Kevin B. Bacon

Affiliation AxikinPharmaceuticals, Inc., San Diego, California, United States of America
⨯

Reader Comments (0)

Pulmonary fibrosis
Is the Subject Area "Pulmonary fibrosis" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Exon mapping
Is the Subject Area "Exon mapping" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Immunohistochemistry techniques
Is the Subject Area "Immunohistochemistry techniques" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Collagens
Is the Subject Area "Collagens" applicable to this article?

Thanks for your feedback.
Macrophages
Is the Subject Area "Macrophages" applicable to this article?

Thanks for your feedback.